| Secondary |
| Hypertension |
28.2% |
| Cardiac Failure |
10.5% |
| Mineral Supplementation |
4.9% |
| Angina Pectoris |
4.7% |
| Renal Transplant |
4.4% |
| Atrial Fibrillation |
4.1% |
| Drug Exposure During Pregnancy |
4.1% |
| Arrhythmia |
3.8% |
| Infection Prophylaxis |
3.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
3.8% |
| Breast Cancer |
3.5% |
| Blood Pressure Management |
3.2% |
| Tachycardia |
3.2% |
| Gastritis Prophylaxis |
2.9% |
| Hyperlipidaemia |
2.9% |
| Chronic Hepatitis C |
2.6% |
| Prophylaxis |
2.6% |
| Basedow's Disease |
2.3% |
| Cardiac Failure Congestive |
2.3% |
| Endotracheal Intubation |
2.3% |
|
| Liver Disorder |
12.5% |
| Thrombocytopenia |
12.5% |
| Arthralgia |
8.3% |
| Multi-organ Failure |
8.3% |
| Tremor |
6.3% |
| Atrial Fibrillation |
4.2% |
| Cardiomegaly |
4.2% |
| Malaise |
4.2% |
| Pneumonia |
4.2% |
| Pulmonary Congestion |
4.2% |
| Pulmonary Fibrosis |
4.2% |
| Shock |
4.2% |
| Solitary Kidney |
4.2% |
| Upper Respiratory Tract Inflammation |
4.2% |
| White Blood Cell Count Decreased |
4.2% |
| Cardio-respiratory Arrest |
2.1% |
| Circulatory Collapse |
2.1% |
| Drug Exposure During Pregnancy |
2.1% |
| Gamma-glutamyltransferase Increased |
2.1% |
| Hypoglycaemia |
2.1% |
|
| Concomitant |
| Hypertension |
26.1% |
| Drug Use For Unknown Indication |
11.9% |
| Prophylaxis |
8.6% |
| Product Used For Unknown Indication |
7.9% |
| Atrial Fibrillation |
6.5% |
| Cardiac Failure |
5.9% |
| Chronic Hepatitis C |
4.8% |
| Rheumatoid Arthritis |
4.7% |
| Diabetes Mellitus |
3.1% |
| Insomnia |
2.7% |
| Hyperlipidaemia |
2.4% |
| Gastritis |
2.3% |
| Angina Pectoris |
2.0% |
| Hepatitis C |
1.9% |
| Type 2 Diabetes Mellitus |
1.9% |
| Cardiac Failure Chronic |
1.7% |
| Constipation |
1.6% |
| Hyperuricaemia |
1.4% |
| Acute Myocardial Infarction |
1.3% |
| Pain |
1.3% |
|
| Renal Impairment |
9.6% |
| Interstitial Lung Disease |
8.2% |
| White Blood Cell Count Decreased |
7.2% |
| Sepsis |
6.8% |
| Cerebral Infarction |
5.5% |
| Pyrexia |
5.5% |
| Renal Failure |
5.1% |
| Renal Failure Acute |
5.1% |
| Rhabdomyolysis |
5.1% |
| Rash |
4.8% |
| Renal Disorder |
4.5% |
| Vomiting |
4.5% |
| Hepatic Function Abnormal |
4.1% |
| Sudden Death |
4.1% |
| Death |
3.8% |
| Platelet Count Decreased |
3.8% |
| Malaise |
3.4% |
| Pancytopenia |
3.4% |
| Intestinal Resection |
2.7% |
| Liver Disorder |
2.7% |
|
| Interacting |
| General Anaesthesia |
25.6% |
| Arrhythmia |
10.3% |
| Atrial Fibrillation |
10.3% |
| Back Pain |
7.7% |
| Non-small Cell Lung Cancer Metastatic |
7.7% |
| Arrhythmia Prophylaxis |
5.1% |
| Cancer Pain |
5.1% |
| Hypocalcaemia |
5.1% |
| Maintenance Of Anaesthesia |
5.1% |
| Osteomyelitis |
5.1% |
| Product Used For Unknown Indication |
5.1% |
| Gastric Ulcer |
2.6% |
| Post-traumatic Pain |
2.6% |
| Prophylaxis |
2.6% |
|
| Ventricular Fibrillation |
50.0% |
| Myocardial Infarction |
25.0% |
| Off Label Use |
25.0% |
|
